Patented Formula

Scalp MED® TECHNOLOGY

BACKED BY 11 PATENT WORLDWIDE

To date, Scalp MED® has been granted 6 U.S. and 5 international patents, with more patents pending. This is a remarkable achievement that is unparalleled in the field of hair loss and hair re-growth. The United States Patent and Trademark Office and other international agencies issue patents to inventors who create products, technology or processes that they deem exceptional enough to warrant protection against copying by others. To attain a patent, an invention must meet a strict set of criteria regarding its usefulness and uniqueness. Following are a few examples of patents awarded to Scalp MED®.

 

BELOW ARE SOME EXAMPLES OF OUR PATENTS:

Scalp MED® US Patent 8,444,960 (issued May 21, 2013)

Topical administration carrier composition and therapeutic formulations comprising same

ABSTRACT

A topical administration carrier composition … suitable for use with compositions containing active ingredients such as minoxidil that are susceptible to volatilization and transdermal penetration in application to the body. The carrier formulation retards the evaporative and systemic migration losses of the active ingredient composition, to provide sustained topical action, in relation to formulations lacking the components of the inventive composition.

DESCRIPTION

FIELD OF THE INVENTION

The present invention relates to topical administration carrier compositions for use in preparing formulations including therapeutic agents and other active ingredients, for administration to scalp, skin and other topical areas of the body.

Scalp MED® US Patent 8,147,815 (issued April 3, 2012)

Scalp MED® US Patent 7,749,489 (issued July 6, 2010)

Scalp MED® China Patent ZL200680051290.6 (issued April, 25, 2012)

Scalp MED® Korea Patent 1020060128936 (issued June 20, 2007)

Scalp MED® European Patent Application 06845368.7 (Patent Pending)

Topical administration carrier composition and therapeutic formulations comprising same

ABSTRACT

A topical administration carrier composition and therapeutic formulations comprising the same composition are provided to delay evaporation loss of solvent from the composition and reduce systemic migration of active ingredients, so that side effects caused by the topical active ingredients in undesired tissues are inhibited. The topical administration carrier composition comprises topical active ingredients, a solvent, and materials capable of delaying or reducing the systemic migration of the topical active ingredients and volatilization of the solvent containing 40-70 wt.% of water, 20-40 wt.% of glycerin and 5-15 wt.% of polysorbate-80. A hair growth formulation comprises the topical administration carrier composition and minoxidil.

Scalp MED® Indian Patent Application 2556/KOLNP/2008 (Patent Pending)

EXPLORE MORE ABOUT

Scalp Med® Science

What to Expect

Customer Success Stories

Money-Back Guarantee**

EXPLORE MORE ABOUT

There are no products